Home
Conditions
Neuroectodermal Tumors

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

6,011 public trials 1,221 recruiting studies

Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Completed

Investigate Safety, Pharmacokinetics and Pharmacodynamics of GSK2118436 & GSK1120212

NCT01072175

Conditions: Cancer, Melanoma, Neoplasms, +10 more
Locations: Novartis Investigative Site Los Angeles, California, United States

Novartis Investigative Site San Francisco, California, United States

Novartis Investigative Site Aurora, Colorado, United States

Novartis Investigative Site New Haven, Connecticut, United States

View all 15 locations

View Trial Details

Completed

Coxsackie Virus A21 Administered Intravenously (IV) for Solid Tumour Cancers (PSX-X04)

NCT00636558

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +27 more
Locations: Cancer Care Centre, St George Hospital Kogarah, New South Wales, Australia

Redcliffe Hospital Redcliffe, Queensland, Australia

View Trial Details

Completed

A Safety Study of Two Intratumoural Doses of Coxsackievirus Type A21 in Melanoma Patients (PSX-X03)

NCT00438009

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +10 more
Locations: Princess Alexandra Hospital Brisbane, Queensland, Australia

View Trial Details

Completed

Dimethyl Fumarate, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

NCT02337426

Conditions: Adult Brain Glioblastoma, Adult Giant Cell Glioblastoma, Adult Gliosarcoma, +11 more
Locations: Virginia Commonwealth University/Massey Cancer Center Richmond, Virginia, United States

View Trial Details

Completed

Intratumoural Administration of Coxsackievirus A21 for the Control of Malignant Melanoma (PXS-X02)

NCT00235482

Conditions: Malignant Melanoma, Melanoma, Neoplasms, +10 more
Locations: Melanoma Unit, Mater Misericordiae Hospital Newcastle, New South Wales, Australia

View Trial Details

Completed

A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.

NCT00428220

Conditions: Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +62 more
Locations: Emory University, Winship Cancer Institute Atlanta, Georgia, United States

Investigational Drug Service Atlanta, Georgia, United States

The Emory Clinic Atlanta, Georgia, United States

Loyola University Medical Center Maywood, Illinois, United States

View all 113 locations

View Trial Details

Completed

Potential Molecular Predictors of Response to Novel Therapies in Metastatic Pancreatic Neuroendocrine Tumors

NCT01603004

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Islet Cell, +16 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Completed

Safety of BBB Disruption Using NaviFUS System in Recurrent Glioblastoma Multiforme (GBM) Patients

NCT03626896

Conditions: Astrocytoma, Brain Diseases, Brain Neoplasms, +16 more
Locations: Linkou Chang Gung Memorial Hospital Taoyuan City, Taiwan

View Trial Details

Completed

Study of JS001 in Patients With Advanced Neuroendocrine Tumors

NCT03167853

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +3 more
Locations: Beijing Cancer Hospital Beijing, Beijing Municipality, China

View Trial Details

Completed

Neoadjuvant Pembrolizumab for Unresectable Stage III and Unresectable Stage IV Melanoma

NCT02306850

Conditions: Melanoma, Metastatic Melanoma, Neoplasms, +13 more
Locations: Saint Louis University Hospital St Louis, Missouri, United States

View Trial Details

Neuroectodermal Tumors

Neuroectodermal Tumors trial results

Related conditions